Effects of salmeterol in patients with persistent asthma receiving inhaled corticosteroid plus theophylline

Respiration

Volumn 74, Issue 6, 2007, Pages 611-616

  Inoue, Hiromasa ^a   Komori, Masashi ^a   Matsumoto, Takafumi ^a   Fukuyama, Satoru ^a   Matsumura, Mikiko ^a   Nakano, Takako ^a   Tsuda, Miyuki ^a   Matsumoto, Koichiro ^a   Kanaya, Akiko ^b   Moriwaki, Atsushi ^a   Aizawa, Hisamichi ^c   Yoshida, Makoto ^a   Nakanishi, Yoichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

^c KURUME UNIVERSITY   (Japan)

Author keywords

Inhaled corticosteroid; Long acting inhaled 2 agonist; Severe asthma; Theophylline

Indexed keywords

CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PLACEBO; SALMETEROL; THEOPHYLLINE;

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; AGED; ALBUTEROL; ASTHMA; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; THEOPHYLLINE; TREATMENT OUTCOME;

EID: 36448976553     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095678     Document Type: Article

References (23)

1. Global Initiative for Asthma: Global strategy for asthma management and prevention. National Institutes of Health: National Heart, Lung, and Blood Institute. Bethesda, National Institutes of Health, 2002.
2. O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, Runnerstrom E, Sandstrom T, Svensson K, Tattersfield A: Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med 2001;164:1392-1397.
3. Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A: Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997;337:1405-1411.
4. Barnes PJ: Theophylline: new perspectives for an old drug. Am J Respir Crit Care Med 2003;167:813-818.
5. Ito K, Lim S, Caramori G, Cosio B, Chung KF, Adcock IM, Barnes PJ: A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci USA 2002;99:8921-8926.
6. Evans DJ, Taylor DA, Zetterstrom O, Chung KF, O'Connor BJ, Barnes PJ: A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med 1997;337:1412-1418.
7. Kidney J, Dominguez M, Taylor PM, Rose M, Chung KF, Barnes PJ: Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy. Am J Respir Crit Care Med 1995;151:1907-1914.
8. Kraft M, Wenzel SE, Bettinger CM, Martin RJ: The effect of salmeterol on nocturnal symptoms, airway function, and inflammation in asthma. Chest 1997;111:1249-1254.
9. +-channel openers and other airway smooth muscle relaxants in isolated guinea-pig trachea. Eur J Pharmacol 1997;326:191-200.
10. Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Selroos O, Sovijarvi A, et al: Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994;331:700-705.
11. van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Kerrebijn KF, Pocock SJ: Remission of childhood asthma after long-term treatment with an inhaled corticosteroid (budesonide): can it be achieved? Dutch CNSLD Study Group. Eur Respir J 1994;7:63-68.
12. Gardiner PV, Ward C, Booth H, Allison A, Hendrick DJ, Walters EH: Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics. Am J Respir Crit Care Med 1994;150:1006-1011.
13. 2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA 2001;285:2583-2593.
14. Lindqvist A, Karjalainen EM, Laitinen LA, Kava T, Altraja A, Pulkkinen M, Halme M, Laitinen A: Salmeterol resolves airway obstruction but does not possess anti-eosinophil efficacy in newly diagnosed asthma: a randomized, double-blind, parallel group biopsy study comparing the effects of salmeterol, fluticasone propionate, and disodium cromoglycate. J Allergy Clin Immunol 2003;112:23-28.
15. Jenne JW, Yeoh HC, Shaughnessy TK, Hur K: Theophylline produces over-additive relaxation of canine tracheal smooth muscle when combined with β-agonists: the doseresponse relationship. Pulm Pharmacol 1992;5:239-249.
16. Laursen LC, Taudorf E, Gnosspelius Y, Gymose E, Weeke B: Long-term oral therapy of asthma with terbutaline and theophylline, alone and combined. Eur J Respir Dis 1985;66:82-90.
17. Rivington RN, Boulet LP, Cote J, Kreisman H, Small DI, Alexander M, Day A, Harsanyi Z, Darke AC: Efficacy of uniphyl, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids. Am J Respir Crit Care Med 1995;151:325-332.
18. Mahler DA, Donohue JF, Barbee RA, Goldman MD, Gross NJ, Wisniewski ME, Yancey SW, Zakes BA, Rickard KA, Anderson WH: Efficacy of salmeterol xinafoate in the treatment of COPD. Chest 1999;115:957-965.
19. ZuWallack RL, Mahler DA, Reilly D, Church N, Emmett A, Rickard K, Knobil K: Salmeterol plus theophylline combination therapy in the treatment of COPD. Chest 2001;119:1661-1670.
20. Cheung D, Wever AM, de GJ, de GC, Steen H, Sterk PJ: Effects of theophylline on tolerance to the bronchoprotective actions of salmeterol in asthmatics in vivo. Am J Respir Crit Care Med 1998;158:792-796.
21. Bennett JA, Smyth ET, Pavord ID, Wilding PJ, Tattersfield AE: Systemic effects of salbutamol and salmeterol in patients with asthma. Thorax 1994;49:771-774.
22. Shrewsbury S, Hallett C: Salmeterol 100 microg: an analysis of its tolerability in single-and chronic-dose studies. Ann Allergy Asthma Immunol 2001;87:465-473.
23. Guhan AR, Cooper S, Oborne J, Lewis S, Bennett J, Tattersfield AE: Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects. Thorax 2000;55:650-656.